TrialThe lancet. Psychiatry2025

Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK.

Anthony J Cleare et al.PubMed ↗Publisher ↗

No numbers read from the abstract.